Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Cantech Letter

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
29.04.CGI Group is still undervalued, this analyst says
29.04.Constellation Software remains a "premium operator", National Bank says
29.04.Medicenna Therapeutics has "elegant science", Research Capital says
28.04.Geovax Labs is a buy, Roth says
28.04.Has Lululemon lost its Mojo?
25.04.Imaflex is an undervalued stock, Beacon says
25.04.Wishpond Technologies opportunities "dwarf" past sales, Beacon says
25.04.WonderFi is a buy, Research Capital says
25.04.Is Spin Master stock a buy?
25.04.Shopify's tariff troubles could be real, Roth says
24.04.Propel Holdings investors can bank on a good year, Ventum says
24.04.IMAX could have a blockbuster year, this analyst says
24.04.Galaxy Digital keeps "Outperform" rating at ATB Capital
24.04.Tesla has price target chopped at Roth
24.04.Colabor Group is a buy, Beacon says
24.04.Decibel Cannabis is deeply undervalued, Ventum says
23.04.Forget First Solar, try 5N Plus, analyst says
23.04.Meta price target slashed at Roth
22.04.Bausch Health is successfully battling generics, Raymond James says
22.04.Can the STATES 2.0 Act resuscitate cannabis stocks?
22.04.RBC cuts price target on Celestica
22.04.GOOGL price target chopped at Roth
22.04.Sylogist is still a buy, Ventum says
21.04.VerticalScope has price target chopped at Beacon
21.04.NervGen Pharma is a high-risk, high-reward stock, analyst says